✦ LIBER ✦

Idiotype vaccines for lymphoma: proof-of-principles and clinical trial failures

✍ Scribed by Bendandi, Maurizio

Book ID: 109948401
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 238 KB
Volume: 9
Category: Article
ISSN: 1474-1776
DOI: 10.1038/nrc2717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Developing idiotype vaccines for lymphom

Developing idiotype vaccines for lymphoma: from preclinical studies to phase III clinical trials

✍ Hyun Jun Park; Sattva S. Neelapu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

Phase I/II clinical trial of sequential

Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides

✍ Antonio Curti; Patrizia Tosi; Patrizia Comoli; Carolina Terragna; Elisa Ferri; C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Endpoints, patient selection, and biomar

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

✍ Marijo Bilusic; James L. Gulley 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 265 KB

[Current Topics in Microbiology and Immu

[Current Topics in Microbiology and Immunology] Vaccines for Pandemic Influenza Volume 333 || Vaccines for Pandemic Influenza: Summary of Recent Clinical Trials

✍ Compans, Richard W.; Orenstein, Walter A. 📂 Article 📅 2009 🏛 Springer Berlin Heidelberg ⚖ 572 KB

Development and evaluation of a standard

Development and evaluation of a standardized questionnaire for identifying adverse events in vaccine clinical trials

✍ P Coplan; L Chiacchierini; A Nikas; J Shea; A Baumritter; K Beutner; W Cassidy; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Interim report of a phase 2 clinical tri

Interim report of a phase 2 clinical trial of lenalidomide for T-cell non-Hodgkin lymphoma

✍ Greg Dueck; Neil Chua; Angeli Prasad; Daygen Finch; Doug Stewart; Darrell White; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract ## BACKGROUND: Novel therapies are needed to improve outcomes in T‐cell lymphomas. The authors report the interim results of a prospective multicenter trial evaluating lenalidomide in T‐cell lymphomas. ## METHODS: Patients with recurrent and refractory T‐cell lymphomas other than myc